Cipher Pharmaceuticals Inc
F:PHE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cipher Pharmaceuticals Inc
F:PHE
|
CA |
|
DBS Group Holdings Ltd
F:DEV
|
SG |
Wall St Price Targets
PHE Price Targets Summary
Cipher Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for PHE is 10.19 EUR with a low forecast of 9.38 EUR and a high forecast of 10.93 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PHE's stock price target?
Price Target
10.19
EUR
According to Wall Street analysts, the average 1-year price target for PHE is 10.19 EUR with a low forecast of 9.38 EUR and a high forecast of 10.93 EUR.
What is the Revenue forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Revenue has been 21%. The projected CAGR for the next 3 years is 12%.
What is the Operating Income forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
31%
The compound annual growth rate for Operating Income over the next 1 year is 31%.
What is the Net Income forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
-3%
The compound annual growth rate for Net Income over the next 3 years is -3%.
